Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
Explore this paper's citation graph
Summary
Light is shed on the roles of melatonin in ovarian cancer treatment from the standpoint of the molecular aspects as well as anti-angiogenetic properties, anti-inflammatory activities, significant antioxidant effects and modulation of various immune system cells and cytokines.
- Type
- review
- Published
- 2019-03-26
- Cited by
- 45
- References
- 115
- Access
- Open access
- OpenAlex
- https://openalex.org/W2940480220
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:85528679
Keywords
Melatonin, Ovarian cancer, Medicine, Angiogenesis, Pineal gland
References
- Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line.
- MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4
- What is known about melatonin, chemotherapy and altered gene expression in breast cancer
- Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy
- Immunhistochemical analysis of Nuclear Factor Kappa Beta expression in etiopathogenesis of ovarian tumors1.
- A generalized theory of carcinogenesis due to chronodisruption.
- Urinary melatonin and risk of ovarian cancer
- Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.
- The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes
- Melatonin synergistically enhances cisplatin‐induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK‐OV‐3 cells
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis.
- Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.
- Tumor suppressor gene E-cadherin and its role in normal and malignant cells
- Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat.
- Glucose as a prognostic factor in ovarian carcinoma
- GLUT1 mRNA and Protein Expression in Ovarian Borderline Tumors and Cancer
- TNF-α in promotion and progression of cancer
- Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin.
- Characterization of Chemically Induced Ovarian Carcinomas in an Ethanol-Preferring Rat Model: Influence of Long-Term Melatonin Treatment
Cited by
- Insights on melatonin as an active pharmacological molecule in cancer prevention: what's new?
- Melatonin attenuates expression of cyclooxygenase-2 (COX-2) in activated microglia induced by lipopolysaccharide (LPS)
- Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
- The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer
- Association Between Night-Shift Work and Cancer Risk: Updated Systematic Review and Meta-Analysis
- Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
- Central and Peripheral Actions of Melatonin on Reproduction in Seasonal and Continuous Breeding Mammals.
- Two neuroendocrine G protein‐coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives
- Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
- LncRNA DLGAP1-AS2 Suppresses the Maturation of miR-16 to Suppress Cell Invasion and Migration of Ovarian Cancer Cells
- Role and Therapeutic Potential of Melatonin in Various Type of Cancers
- Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
- Knockdown of ZNF280A inhibits the development and progression of ovarian cancer
- Melatonin Sensitize the Ovarian Cancer Cells to Cisplatin through suppression of PI3K/Akt pathway
- The promising oncostatic effects of melatonin against ovarian cancer
- Anticancer effects of melatonin via regulating lncRNA JPX‐Wnt/β‐catenin signalling pathway in human osteosarcoma cells
- Acute melatonin administration improves exercise tolerance and the metabolic recovery after exhaustive effort
- The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence
- The proteomic landscape of ovarian cancer cells in response to melatonin.
- Molecular and cellular mechanisms of melatonin in breast cancer.
Related papers
- Melatonin secretion profile after experimental pineal gland compression in rats.
- A clinical study of the pineal gland activity in oncologic patients
- Antitumor activity of the pineal gland: effect of unidentified substances versus the effect of melatonin.
- Melatonin Synthesis in the Hen Pineal Gland and its Control by Light
- Complementary and alternative medicines patients are talking about: melatonin.
- Effects of time, photoperiod, and pinealectomy on ocular and plasma melatonin concentrations in the chick.
- Melatonin in rat pineal gland and serum; rapid parallel decline after light exposure at night.
- MicroRNAs in the Pineal Gland
- Melatonin: reproductive effects.